Clinical Trial Update: Cannabinoids for Taxane Induced Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cannabinoids for taxane-induced peripheral neuropathy has been terminated, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Status: TERMINATED | Results posted: 2023-01-26